On the other hand, extracellular vesicles derived from hUC‐MSCs deliver miR‐302a to the local area of endometrial cancer, inhibit the signals of cyclin D1 and AKT1, and prevent the progression of endometrial cancer (Li, Liu, et al., 2019). Here, AKT1 is linked to endometrial cancer.